"Broder Will Focus on Prevention at Cancer Institute"

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

"Broder Will Focus on Prevention at Cancer Institute"

Wall Street Journal (12/27/88), P. B2
Chase, Marilyn

Abstract: The appointment of Dr. Samuel Broder, a 43-year-old cancer and AIDS researcher, to head the National Cancer Institute (NCI) is a vote for uncompromising science, say his colleagues. Broder plans on maintaining his AIDS laboratory while he serves as NCI director. "Investigator-instigated research," in which researchers inside and outside NCI receive grants to pursue innovative research, will be a high priority of his, Broder says. The National Cooperative Drug Discovery Program and other projects should help spur innovation by linking NCI with a "critical mass of talent in the private sector" through academic-industrial partnerships. Broder favors avoiding controversies such as Burroughs-Wellcome's decision to sell the AIDS drug AZT for $8,000 a year by urging the development of more drugs to stimulate competition, rather than through price controls. The new director said he favors taking steps "where appropriate" to remove bureAUcratic barriers from the development of new drugs.
881227
AD880420

Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .